Clinical studies recruiting near Caen

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
Phase 1/Phase 2 · Institut d'Hématologie de Basse Normandie - Service Hématolo · The Lymphoma Academic Research Organisation · NCT07018752 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Centre François Baclesse · Eli Lilly and Company · NCT07218380 Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Phase 3 · CHU Caen · Fondation Hôpital Saint-Joseph · NCT05674994 Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · Centre Francois Baclesse · Daiichi Sankyo · NCT07022483 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Centre François Baclesse ( Site 1318) · Merck Sharp & Dohme LLC · NCT06393374 Relation Between Psychoactive Drugs Overdosage and Severity of Falls in Elderly People
NA · Caen University Hospital · University Hospital, Caen · NCT05991037 Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring
Phase 2 · Centre François Baclesse · Centre Oscar Lambret · NCT05500391 A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Gr
Phase 2 · Centre Francois Baclesse /ID# 272204 · AbbVie · NCT06682988 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Centre Francois Baclesse · Hoffmann-La Roche · NCT06793215 Short Versus Long Antiplatelet Therapy After TAVI
Phase 3 · Caen University Hospital · University Hospital, Caen · NCT06518317 Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome
Phase N/A · CHU de Caen-Normandie · Nantes University Hospital · NCT06244433 TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)
Phase N/A · Crlcc Francois Baclesse · NovoCure Ltd. · NCT06924099 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Centre François Baclesse ( Site 1201) · Merck Sharp & Dohme LLC · NCT07216703 Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete
NA · CHU Caen · Institut Curie · NCT04731610 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Gra
Phase 2 · Centre François Baclesse · Centre Leon Berard · NCT03624244 Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More
Phase 2 · CHU Caen · Assistance Publique - Hôpitaux de Paris · NCT06646497 Development of Tumor Organoids From Undifferentiated Primary Carcinomas to Guide Therapeutic Decisions
Phase N/A · Centre François Baclesse · Centre Francois Baclesse · NCT06612827 Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment
Phase 1/Phase 2 · Centre François Baclesse · Hospices Civils de Lyon · NCT04396223 PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years
Phase 3 · CHU Côte de Nacre · Assistance Publique - Hôpitaux de Paris · NCT05387954 Health Effects of CArdiac FluoRoscopy and MOderN RadIotherapy in PediatriCs - Radiotherapy
Phase N/A · Centre Régional François Baclesse · Institut National de la Santé Et de la Recherche Médicale, F · NCT04746729 Validation of a Rapid Screening Tool for Anxiety-depressive Disorders in Children, Adolescents and Young Adults Treated
Phase N/A · Centre Hospitalier Universitaire Caen Normandie · Centre Hospitalier Universitaire de Saint Etienne · NCT07117058 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Centre Hospitalier Universitaire de Caen - Hôpital Côte de N · Merck Sharp & Dohme LLC · NCT06077760 Interest of Bilateral Basic Tongue Mucosectomy Assisted by Robot or Laser in Combination with Tonsillectomy in the Asses
Phase 2 · Centre François Baclesse · Centre Francois Baclesse · NCT04767048 Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma
Phase 3 · Cac - François Baclesse · Federation Francophone de Cancerologie Digestive · NCT07270991 Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Phase 2/Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05948943 FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum
Phase 2 · Centre Francois Baclesse · Centre Leon Berard · NCT06393816 Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care
NA · CHU CAEN Normandie · University Hospital, Caen · NCT07359287 A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulc
Phase 4 · CHU Caen Hôpital Côte de Nacre · Groupe d'Etude Therapeutique des Affections Inflammatoires D · NCT04183608 Alcohol Consumption: Norms, Identities, & Motivations
NA · CAEN University Hospital · University Hospital, Caen · NCT06447350

Look up another city

Look up another condition